LexDanaLexDanabeta
Inventor

Gerald W. Fischer

Inventor
Bethesda, MD, US

Overview

44→
Patents
1988–2021
Patent span
Chemistry
Primary field (CPC C)

Patents· 44 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes20%
C07KPeptides18%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms18%
C12NMicroorganisms or enzymes15%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations14%
G01NInvestigating or analysing materials by determining their chemical or physical properties5%
Y02ATechnologies for adaptation to climate change5%
G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biology2%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests2%
A61LMethods or apparatus for sterilising materials or objects in general1%
PatentTitleYear
11,041,215PCR ready compositions and methods for detecting and identifying nucleic acid sequences202111,041,216Compositions and methods for detecting and quantifying nucleic acid sequences in blood samples202110,870,878Aqueous compositions that maintains fidelity of the nucleic acid sequences of a biological specimen202010,787,504Antibodies that modulate immunity to drug resistant and latent MTB infections202010,596,250Methods of treating and preventing influenza infections202010,414,819Monoclonal antibodies that modulate immunity to MTB and enhance immune clearance201910,370,437Antibodies that modulate immunity to drug resistant and latent MTB infections201910,087,439Rapid methods for the extraction of nucleic acids from biological samples201810,004,799Composite antigenic sequences and vaccines20189,976,136Rapid methods for the extraction of nucleic acids from biological samples20189,821,047'Enhancing immunity to tuberculosis'20179,814,766'Multimodal antimicrobial therapy'20179,777,045'Immunogenic compositions and methods'20179,683,256'Biological specimen collection and transport system'20179,598,462'Composite antigenic sequences and vaccines'20179,598,737'Next generation genomic sequencing methods'20179,481,912'Compositions and methods for detecting and identifying nucleic acid sequences in biological samples'20169,416,416'Biological specimen collection/transport compositions and methods'20169,388,220'Immunogenic compositions and methods'20169,365,904'Ion torrent genomic sequencing'20169,212,399'Biological specimen collection and transport system and method of use'20159,080,204'Compositions and methods for rapid, real-time detection of influenza a virus (H1N1) Swine 2009'20158,821,885'Immunogenic compositions and methods'20148,669,240'Biological specimen collection and transport system and method of use'20148,652,782'Compositions and methods for detecting, identifying and quantitating mycobacterial-specific nucleic acids'20148,415,330'Biological specimen collection and transport system and method of use'20138,372,958'Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram posiive bacteria'20138,293,467'Biological specimen collection and transport system and methods of use'20128,097,419'Compositions and method for rapid, real-time detection of influenza A virus (H1N1) swine 2009'20128,084,443'Biological specimen collection and transport system and methods of use'20118,080,645'Biological specimen collection/transport compositions and methods'20117,884,198'Polynucleotides encoding humanized and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria'20117,777,017'Nucleic acids encoding opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria'20107,511,122'Humanized and chimeric antibodies specific for lipoteichoic acid of GRAM positive bacteria'20097,279,162'Isolated broadly reactive opsonic immunoglobulin for treating a pathogenic coagulase-negative staphylococcus infection'20077,250,494'Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria'20077,169,903'Multifunctional monoclonal antibodies directed to peptidoglycan of gram-positive bacteria'20076,939,543'Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria'20056,632,432'Directed human immune globulin for the prevention and treatment of staphylococcal infections'20036,610,293'Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria'20035,955,074'Directed human immune globulin for the prevention and treatment of staphylococcal infections'19995,571,511'Broadly reactive opsonic antibodies that react with common staphylococcal antigens'19964,954,449'Human monoclonal antibody reactive with polyribosylribitol phosphate'19904,744,982'Human monoclonal antibody reactive with polyribosylribitol phosphate'1988

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1988–2016Patents assigned to FISCHER GERALD W (10)· patent assignee history
1988–1990Based in Gaithersburg, MD, US· patent location history
1996–2021Based in Bethesda, MD, US· patent location history
1999–2009Patents assigned to JACKSON H M FOUND MILITARY MED (5)· patent assignee history
2007–2013Patents assigned to BIOSYNEXUS INC (4)· patent assignee history
2011–2021Patents assigned to LONGHORN VACCINES & DIAGNOSTICS LLC (30)· patent assignee history
2011–2016Patents assigned to DAUM LUKE T (8)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
LONGHORN VACCINES & DIAGNOSTICS LLC302011–2021
FISCHER GERALD Wself101988–2016
DAUM LUKE T82011–2016
JACKSON H M FOUND MILITARY MED51999–2009
BIOSYNEXUS INC42007–2013
Locations
LocationPatentsSpan
Bethesda, Maryland, US421996–2021
Gaithersburg, Maryland, US21988–1990